Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Shah Gaurav
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   621,339    

Indirect Shares

  406,238      
Direct Value   $14,514,479    

Indirect Value

  $9,489,720      
Total Shares   1,027,577      
Total Value   $24,004,199      


Rocket Pharmaceuticals
 $14,514,479 Rocket Pharmaceuticals
 $14,514,479
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    1   
    4    

     Stock price went up :

    1   
    3    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   1.0   
   3.0   
     Percentage Gain/Loss :
   5.2%
 59.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rocket Pharmaceuticals RCKT 2024-02-16 621,339 2024-02-16 406,238    Premium*  
* Premium Members only  

Records found :    23         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
RCKT Rocket Pharmaceuticals CEO   •       •      –    2024-02-16 4 A $0.00 $0 D/D 66,577 621,339 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2024-02-16 4 S $29.84 $604,876 D/D (20,272) 554,762 0 %
RCKT Rocket Pharmaceuticals CEO   •       •      –    2024-02-14 4 OE $0.00 $0 D/D 46,828 575,034 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2023-11-14 4 OE $0.00 $0 D/D 7,979 532,833 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2023-08-17 4 S $15.47 $73,750 D/D (4,767) 524,854 0 %
RCKT Rocket Pharmaceuticals CEO   •       •      –    2023-08-14 4 OE $0.00 $0 D/D 7,979 529,621 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2023-05-17 4 S $21.38 $88,108 D/D (4,122) 521,642 0 %
RCKT Rocket Pharmaceuticals CEO   •       •      –    2023-05-14 4 OE $0.00 $0 D/D 7,979 525,764 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2023-02-17 4 S $19.06 $232,418 D/D (12,194) 536,885 0 %
RCKT Rocket Pharmaceuticals CEO   •       •      –    2023-02-14 4/A OE $0.00 $0 D/D 31,440 549,079 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2022-02-07 4 B $17.34 $381,513 D/D 22,000 517,639 0.01 %
RCKT Rocket Pharmaceuticals CEO   •       •      –    2021-04-01 4 D $45.21 $1,032,554 D/D (22,266) 495,639 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2021-03-31 4 D $45.94 $344,235 D/D (7,493) 517,905 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2021-03-31 4 D $44.24 $3,887,647 D/D (87,353) 525,398 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2021-03-31 4 OE $1.69 $128,237 D/D 75,880 612,751 0 -
RCKT Rocket Pharmaceuticals CEO   •       •      –    2021-03-30 4 D $41.80 $3,720,492 D/D (85,888) 536,871 0 -
RCKT Rocket Pharmaceuticals President & CEO   •       •      –    2020-03-24 4 OE $0.43 $39,098 D/D 90,925 1,061,642 0 -
RCKT Rocket Pharmaceuticals President & CEO   •       •      –    2020-03-24 4 D $13.78 $449,848 D/D (32,645) 1,028,997 0 -
RCKT Rocket Pharmaceuticals President & CEO   •       •      –    2020-02-25 4 D $20.15 $125,595 D/D (6,233) 970,717 0 -
RCKT Rocket Pharmaceuticals President & CEO   •       •      –    2020-02-25 4 OE $0.43 $125,628 D/D 290,000 976,950 0 -
RCKT Rocket Pharmaceuticals See Remarks   •       •      –    2019-03-05 4 AS $16.90 $422,500 D/D (25,000) 686,950 0 -
RCKT Rocket Pharmaceuticals See Remarks   •       •      –    2019-03-04 4 AS $17.28 $430,272 D/D (24,900) 711,950 0 -
RCKT Rocket Pharmaceuticals See Remarks   •       •      –    2019-03-01 4 AS $17.34 $433,500 D/D (25,000) 736,850 0 -

  23  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed